ability in these estimates may be due in part to differences in the measures used to assess depression. The Beck Depression Inventory (BDI) has been used in over 500 reported studies3 and is currently gaining increasing recognition as a reliable measure of depression symptomatology in Parkinson's disease patients. 4 8 However, one major criticism of this scale is that it is heavily weighted toward somatic complaints,9 making it difficult to distinguish between symptoms of depression and symptoms of the disease.'0 It can be argued that Parkinsonian patients are more likely to endorse somatic items on depression scales because of the characteristics of the disease and not necessarily because they are depressed. Patients with Par- kinson's disease often complain of lack of energy, difficulty in performing routine tasks, fatigue and sleep disruption.
The assertion that the somatic content of the BDI makes it difficult to separate symptoms of depression from manifestations of Parkinson's disease is logical. However, there are no empirical studies which have demonstrated that the somatic items detract from the validity and reliability of the BDI as a measure of depression in Parkinson's disease patients. The purpose of this study was to determine whether the somatic items on the BDI detracted from its internal consistency and validity as a measure of depression with Parkinson's disease patients. The last analysis conducted consisted of a principal axis factor analysis on 97 Parkinson's disease patients with complete data on the MBHI (PP and FD), BDI (NS and S) and the motor indices (R, B, and T) from the neurological examination. The purpose of this analysis was to determine whether two factors, depression 4nd Parkinson's disease symptoms, could explain the'intercorrelations among these measures, with the depression subscales (NS, PP, and FD) loading on the first factor and the somatic items (S) and Parkinson's disease symptoms (R, B, and T) on the second factor.
Although three eigenvalues were greater than unity, a scree plot indicated that two factors provided a satisfactory solution and were rotated to varimax criterion. Factor loadings greater than 030 are shown in table 4 . It is evident from the loadings that the depression subscales define the first factor. The rigidity and bradykinesia measures define Factor 2. Relevant to our study is the finding that the somatic sub- This study was designed to assess the validity and internal consistency of the BDI when used on a sample of patients with Parkinson's disease. The primary purpose was to determine whether the somatic component of the BDI measured symptoms of the disease or manifestations of depression.
Our data confirm previous studies2 5 7 10 16-19 showing that Parkinson's disease patients exhibit significantly more depressive symptomatology than controls. The findings are also consistent with a recent study by Gotham et al1 who reported that Parkinson's disease subjects tend to endorse somatic items as one part of their depressive symptomatology. In our study, although there was a tendency for both Parkinson's disease and control subjects to rate somatic items more strongly than nonsomatic ones, Parkinson's disease patients were still significantly more depressed than normals on both the BDI as well as two subscales of the MBHI. It is of note that the MBHI was developed for use on a medical population and does not contain somatic items. This suggests that depression in Parkinson's disease patients is not a somatic artifact.
The overall internal consistency of the BDI calculated for the Parkinson's disease group compares favourably with the internal reliability reported by Beck20 in early psychometric studies. Our data suggest that the internal consistency is actually higher for Parkinson's disease subjects, indicating stronger item similarity for Parkinson's disease as compared with control subjects. In fact, when somatic items are omitted from the BDI, internal consistency does not improve in a meaningful way.
The first factor analysis showed that all measures of depression define one factor which is strikingly similar between the Parkinson's disease and control groups. This indicates that the BDI has factorial validity when measuring depression in Parkinson's disease as well as control subjects. If 
